U.S. Markets closed
  • S&P Futures

    3,786.75
    -30.00 (-0.79%)
     
  • Dow Futures

    31,056.00
    -180.00 (-0.58%)
     
  • Nasdaq Futures

    12,548.50
    -133.25 (-1.05%)
     
  • Russell 2000 Futures

    2,182.10
    -23.70 (-1.07%)
     
  • Crude Oil

    61.72
    +0.44 (+0.72%)
     
  • Gold

    1,711.20
    -4.60 (-0.27%)
     
  • Silver

    26.17
    -0.22 (-0.84%)
     
  • EUR/USD

    1.2057
    -0.0010 (-0.0844%)
     
  • 10-Yr Bond

    1.4700
    +0.0550 (+3.89%)
     
  • Vix

    26.67
    +2.57 (+10.66%)
     
  • GBP/USD

    1.3948
    -0.0004 (-0.0321%)
     
  • USD/JPY

    107.0400
    +0.0380 (+0.0355%)
     
  • BTC-USD

    49,747.37
    +931.98 (+1.91%)
     
  • CMC Crypto 200

    992.08
    +3.98 (+0.40%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    28,773.10
    -786.00 (-2.66%)
     

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BIIB, PINS and KNDI

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / January 12, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Biogen Inc. (NASDAQ:BIIB)

Investors Affected: October 22, 2019 - November 6, 2019

A class action has commenced on behalf of certain shareholders in Biogen Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the larger dataset did not provide necessary data regarding aducanumab's effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding the effectiveness of aducanumab, Biogen's investigational human monoclonal antibody studied for the treatment of early Alzheimer's disease; (3) the PRIME study did not and would not provide necessary data regarding aducanumab's effectiveness; (4) the data provided by the Company to the U.S. Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/biogen-inc-loss-submission-form/?id=12104&from=1

Pinterest, Inc. (NYSE:PINS)

Investors Affected: May 16, 2019 - November 1, 2019

A class action has commenced on behalf of certain shareholders in Pinterest, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's addressable market in the U.S. was reaching its maximum capacity; (ii) which significantly decelerated Pinterest's future ability to monetize on U.S. average revenue per user; (iii) Pinterest was at an increased risk of losing advertising revenue; (iv) and as a result, Defendants' public statements were materially false and misleading at all relevant times or lacked a reasonable basis and omitted material facts.

Shareholders may find more information at https://securitiesclasslaw.com/securities/pinterest-inc-loss-submission-form/?id=12104&from=1

Kandi Technologies Group, Inc. (NASDAQ:KNDI)

Investors Affected: March 15, 2019 - November 27, 2020

A class action has commenced on behalf of certain shareholders in Kandi Technologies Group, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Kandi artificially inflated its reported revenues through undisclosed related party transactions, or otherwise had relationships with key customers that indicated those customers did not have an arms length relationship with Kandi; (ii) the majority of Kandi's sales in the past year had been to undisclosed related parties and/or parties with such a close relationship and history with Kandi that it cast doubt on the arms-length nature of their relationship; (iii) all the foregoing, once revealed, was foreseeably likely to cast doubt on the validity of Kandi's reported revenues and, in turn, have a foreseeable negative impact on the Company's reputation and valuation; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/kandi-technologies-group-inc-loss-submission-form/?id=12104&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm



View source version on accesswire.com:
https://www.accesswire.com/623986/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-BIIB-PINS-and-KNDI